Albuminuria according to status of autoimmunity and insulin sensitivity among youth with type 1 and type 2 diabetes

Diabetes Care

Volumn 36, Issue 11, 2013, Pages 3633-3638

  Mottl, Amy K ^a   Lauer, Abigail ^b   Dabelea, Dana ^c   Maahs, David M ^d   D'Agostino Jr , Ralph B ^b   Dolan, Larry M ^e   Gilliam, Lisa K ^f   Lawrence, Jean M ^g   Rodriguez, Beatriz ^h   Marcovina, Santica M ^f   Imperatore, Giuseppina ⁱ   Shankar, Roopa Kanakatti ^e   Afkarian, Maryam ^f   Reynolds, Kristi ^g   Liese, Angela D ^j   Mauer, Michael ^k   Mayer Davis, Elizabeth J ^l  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF COLORADO DENVER   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g Kuakini Medical Center ^*  (United States)

^h KUAKINI MEDICAL CENTER   (United States)

ⁱ NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^j UNIVERSITY OF SOUTH CAROLINA   (United States)

^k UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^l IL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIGEN; AUTOANTIBODY; CREATININE; GLUTAMATE DECARBOXYLASE; INSULINOMA ASSOCIATED PROTEIN 2 ANTIGEN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; INSULIN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE;

ALASKA NATIVE; ALBUMINURIA; AMERICAN INDIAN; ARTICLE; ASIAN; AUTOIMMUNITY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETOGENESIS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ETHNIC GROUP; FEMALE; HEALTH STATUS; HISPANIC; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SENSITIVITY SCORE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON HISPANIC BLACK; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PACIFIC ISLANDER; POST HOC ANALYSIS; PROTEIN URINE LEVEL; RATING SCALE; REGRESSION ANALYSIS; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINARY ALBUMIN CREATININE RATIO; ADOLESCENT; BLOOD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; IMMUNOLOGY; UNITED STATES; URINE; YOUNG ADULT;

ADOLESCENT; ALBUMINURIA; AUTOANTIBODIES; AUTOIMMUNITY; CHILD; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; INSULIN; INSULIN RESISTANCE; LONGITUDINAL STUDIES; MALE; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8; UNITED STATES; YOUNG ADULT;

EID: 84891856800     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0568     Document Type: Article

References (38)

1. Pugh JA, Medina R, Ramirez M. Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy. Diabetologia 1993;36:1094-1098
2. Hasslacher C, Ritz E, Wahl P, Michael C. Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Transplant 1989;4:859-863
3. Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetesmellitus. JAMA 2003;289:3273-3277
4. Molitch ME, Steffes M, Sun W, et al.; Epidemiology of Diabetes Interventions and Complications Study Group. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care 2010;33:1536-1543
5. Maahs DM, Snively BM, Bell RA, et al. Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study. Diabetes Care 2007;30: 2593-2598
6. Dart AB, Sellers EA, Martens PJ, Rigatto C, Brownell MD, Dean HJ. High burden of kidney disease in youth-onset type 2 diabetes. Diabetes Care 2012;35:1265-1271
7. Eppens MC, Craig ME, Cusumano J, et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 2006;29: 1300-1306
8. Tripathi A, Rizvi AA, Knight LM, Jerrell JM. Prevalence and impact of initial misclassification of pediatric type 1 diabetes mellitus. South Med J 2012;105:513-517
9. Liu LL, Lawrence JM, Davis C, et al.; SEARCH for Diabetes in Youth Study Group. Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes 2010;11:4-11
10. Nadeau KJ, Regensteiner JG, Bauer TA, et al. Insulin resistance in adolescentswith type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab 2010;95:513-521
11. Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial. Diabetes Care 2007;30:707-712
12. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE. Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study. Kidney Int 2002; 62:963-970
13. SEARCH Study Group. SEARCH for Diabetes in Youth: amulticenter study of the prevalence, incidence and classification of diabetes mellitus in youth. Control Clin Trials 2004;25:458-471
14. Ingram DD, Parker JD, Schenker N, et al. United States Census 2000 population with bridged race categories. Vital Health Stat 2 2003 (135):1-55
15. Fernández JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004;145:439-444
16. Rodriguez BL, Fujimoto WY, Mayer-Davis EJ, et al. Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study. Diabetes Care 2006;29:1891-1896
17. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002;109:45-60
18. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011;34(Suppl. 1):S11-S61
19. KDOQI. KDOQI Clinical Practice Guidelines andClinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007;49(Suppl. 2):S12-S154
20. Bonifacio E, Yu L, Williams AK, et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for National Institute of Diabetes and Digestive and Kidney Diseases consortia. J Clin Endocrinol Metab 2010;95: 3360-3367
21. Dabelea D, D'Agostino RB Jr, Mason CC, et al. Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia 2011;54:78-86
22. Dabelea D, Pihoker C, Talton JW, et al.; SEARCH for Diabetes in Youth Study. Etiological approach to characterization of diabetes type: the SEARCH for Diabetes in Youth Study. Diabetes Care 2011;34: 1628-1633
23. Teupe B, Bergis K. Epidemiological evidence for "double diabetes." Lancet 1991; 337:361-362
24. Chillarón JJ, Goday A, Flores-Le-Roux JA, et al. Estimated glucose disposal rate in assessment of the metabolic syndrome and microvascular complications in patients with type 1 diabetes. J Clin Endocrinol Metab 2009;94:3530-3534
25. Olson JC, Erbey JR, Williams KV, et al. Subclinical atherosclerosis and estimated glucose disposal rate as predictors of mortality in type 1 diabetes. Ann Epidemiol 2002;12:331-337
26. Rowley KG, Iser DM, Best JD, O'Dea K, Leonard D, McDermott R. Albuminuria in Australian Aboriginal people: prevalence and associations with components of the metabolic syndrome. Diabetologia 2000; 43:1397-1403
27. Mykkänen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 1998;47:793-800
28. Nosadini R, Cipollina MR, Solini A, et al. Close relationship between microalbuminuria and insulin resistance in essential hypertension and non-insulin dependent diabetes mellitus. J Am Soc Nephrol 1992;3(Suppl.):S56-S63
29. Bonnet F, Marre M, Halimi JM, et al.; DESIR Study Group. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. J Hypertens 2006;24:1157-1163
30. Diez-Sampedro A, Lenz O, Fornoni A. Podocytopathy in diabetes: a metabolic and endocrine disorder. Am J Kidney Dis 2011;58:637-646
31. Welsh GI, Coward RJ. Podocytes, glucose and insulin. Curr Opin Nephrol Hypertens 2010;19:379-384
32. Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 2008;34:2-11
33. Kang YS, Song HK, Lee MH, et al. Visfatin is upregulated in type-2 diabetic rats and targets renal cells. Kidney Int 2010;78: 170-181
34. Fioretto P, Stehouwer CD, Mauer M, et al. Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure. Diabetologia 1998;41: 233-236
35. Brandt JR, Jacobs A, Raissy HH, et al. Orthostatic proteinuria and the spectrum of diurnal variability of urinary protein excretion in healthy children. Pediatr Nephrol 2010;25:1131-1137
36. McHardy KC, Gann ME, Ross IS, Pearson DW. A simple approach to screening for microalbuminuria in a type 1 (insulindependent) diabetic population. Ann Clin Biochem 1991;28:450-455
37. Énée E, Kratzer R, Arnoux JB, et al. ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes. Diabetes 2012;61:1779-1784
38. WilliamsKV, Erbey JR, BeckerD,Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 2000;49:626-632